Soft Power and Vaccine Diplomacy: An Analysis of China's Global Image Enhancement during the COVID-19 Pandemic

Author:

Bilal Zubair ,Waseem SibraORCID,Shahid KhushbakhtORCID

Abstract

The COVID-19 pandemic amplified global rivalries. The US blamed China for the viral outbreak in Wuhan. Many in the US, including former President Trump and his aides, called the Coronavirus the “Chinese Virus” or the “Wuhan virus,” raising anti-Chinese sentiments in the West. At the same time, Beijing sought to use this opportunity to practice its vaccine diplomacy to shore up its international stature as a world power amid the pandemic. In this pursuit, China provided vaccines and personal protective equipment (PPEs) as global public goods, particularly to the global South. Using both primary and secondary sources and relying on a mixed approach for data analysis, this paper analyzes the effectiveness of China’s vaccine diplomacy during Covid-19.  It explores China’s use of soft power through social media, including infodemics and ‘twiplomacy’ to bolster its image. The article also assesses the role of China’s ‘wolf warrior diplomacy’ that manipulated the facts to advance its propaganda. Conclusively, this paper argues that Chinese vaccine diplomacy served as an effective tool to enhance China’s global image as a responsible great power, albeit undermined through tactics such as the manipulation of information.

Reference82 articles.

1. Yana Demeshko et al., "The U.S. and Russia could join forces to get people vaccinated. They did before," The Washington Post, accessed January 7, 2023, https://www.washingtonpost.com/outlook/2021/09/01/us-russia-could-join-forces-get-people-vaccinated-they-did-before/.

2. Ibid.

3. "The Outbreak of COVID-19: An Overview," PubMed Central (PMC), accessed May 11, 2023, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153464/.

4. Ibid.

5. G. J. Ikenberry, "Soft Power: The Means to Success in World Politics," Foreign Affairs, accessed January 30, 2023.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3